Independent kratom directory

Find Mitragyna near you — brands, strains, and stores.

Clinical guidance on alkaloid profiles and market transparency. Medically reviewed by Dr. Irvine Russell M.D., UC Irvine School of Medicine.

Specimen No. 24-04-MS

Leaf Alkaloid Profile

Average standard distribution

Mitragynine ~1.5% – 2.0%
7-Hydroxymitragynine <0.02%

*Percentages reflect raw Mitragyna speciosa powder. Extract-based products vary significantly.

30k+Monthly Searches
7Brands Indexed
6Strain Profiles
Medically Reviewed — Dr. Russell M.D.

Start here / Three questions

Most kratom users have first

The Directory

Featured Brands

View all →
Kratom extract shots

OPMS

"The most-distributed kratom brand in US smoke-shop retail"

Read profile →
Kratom extract shots

MIT 45

"Ultra-concentrated kratom extract shots"

Read profile →
Powder

Club 13

"Mainstream kratom powder, capsule, and extract brand"

Read profile →
Powder

Earth Kratom

"Budget-friendly leaf kratom for smoke-shop retail"

Read profile →
Powder

Super Speciosa

"Premium direct-to-consumer kratom with lab transparency"

Read profile →
Powder

Whole Herbs

"Widely-stocked leaf kratom in major smoke-shop chains"

Read profile →

Red · White · Green

Vein-color taxonomy.

Browse strains →

Taxonomy

Kratom Strain Index

Harm reduction first

Kratom is biologically active — start low, understand withdrawal.

Kratom (Mitragyna speciosa) interacts primarily with mu-opioid receptors as a partial agonist. While it does not recruit beta-arrestin-2 as strongly as traditional opioids, prolonged frequent use leads to downregulation and physical dependence.

The risk profile shifts dramatically between raw leaf powder and highly concentrated extract shots (7-OH). We recommend verifying AKA-GMP compliance and laboratory COAs for every purchase.

Safety & Harm Reduction →

Dependence & Tolerance

Physical dependence can occur with regular daily use. Cessation after long-term high dosage typically initiates opioid-like withdrawal symptoms including insomnia, RLS, and anxiety.

Legal Status (US)

Federally legal, but banned in AL, AR, IN, RI, VT, WI. Many municipalities (Sarasota FL, San Diego CA) have local bans.

Lab Transparency

Demand a COA.

Reading lab results →
Clinical Advisory

FDA 7-OH Scheduling Watch

The FDA has signaled intent to schedule 7-hydroxymitragynine. Products featuring elevated 7-OH (Hydroxie tablets, 7 OHMZ, 7 Tabz) carry materially higher dependence risk than leaf kratom.